7JPX image
Deposition Date 2020-08-10
Release Date 2020-11-18
Last Version Date 2025-05-21
Entry Detail
PDB ID:
7JPX
Title:
Rabbit Cav1.1 in the presence of 100 micromolar amlodipine in nanodiscs at 2.9 Angstrom resolution
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.90 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent L-type calcium channel subunit alpha-1S
Gene (Uniprot):CACNA1S
Chain IDs:A
Chain Length:1873
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent calcium channel gamma-1 subunit
Gene (Uniprot):CACNG1
Chain IDs:B (auth: E)
Chain Length:222
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent calcium channel subunit alpha-2/delta-1
Gene (Uniprot):CACNA2D1
Chain IDs:C (auth: F)
Chain Length:1105
Number of Molecules:1
Biological Source:Oryctolagus cuniculus
Primary Citation
Structural Basis of the Modulation of the Voltage-Gated Calcium Ion Channel Ca v 1.1 by Dihydropyridine Compounds*.
Angew.Chem.Int.Ed.Engl. 60 3131 3137 (2021)
PMID: 33125829 DOI: 10.1002/anie.202011793

Abstact

1,4-Dihydropyridines (DHP), the most commonly used antihypertensives, function by inhibiting the L-type voltage-gated Ca2+ (Cav) channels. DHP compounds exhibit chirality-specific antagonistic or agonistic effects. The structure of rabbit Cav 1.1 bound to an achiral drug nifedipine reveals the general binding mode for DHP drugs, but the molecular basis for chiral specificity remained elusive. Herein, we report five cryo-EM structures of nanodisc-embedded Cav 1.1 in the presence of the bestselling drug amlodipine, a DHP antagonist (R)-(+)-Bay K8644, and a titration of its agonistic enantiomer (S)-(-)-Bay K8644 at resolutions of 2.9-3.4 Å. The amlodipine-bound structure reveals the molecular basis for the high efficacy of the drug. All structures with the addition of the Bay K8644 enantiomers exhibit similar inactivated conformations, suggesting that (S)-(-)-Bay K8644, when acting as an agonist, is insufficient to lock the activated state of the channel for a prolonged duration.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback